z-logo
open-access-imgOpen Access
Modulation of Iris Sphincter and Ciliary Muscles by Urocortin 2
Author(s) -
Marta Tavares-Silva,
Diogo SantosFerreira,
Samuel Cardoso,
Ana Rita Marcos Raimundo,
João BarbosaBreda,
Leite-Moreira Af,
Amândio RochaSousa
Publication year - 2018
Publication title -
physiological research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.647
H-Index - 70
eISSN - 1802-9973
pISSN - 0862-8408
DOI - 10.33549/physiolres.933646
Subject(s) - urocortin , carbachol , medicine , endocrinology , contraction (grammar) , chemistry , sphincter , nitric oxide , muscle relaxation , isometric exercise , muscle contraction , ciliary muscle , biology , anatomy , stimulation , neuroscience , receptor , accommodation
Urocortin 2 (UCN2) is a peptide related to corticotropin-releasing factor, capable of activating CRF-R2. Among its multisystemic effects, it has actions in all 3 muscle subtypes. This study’s aim was to determine its potential role in two of the intrinsic eye muscle kinetics. Strips of iris sphincter (rabbit) and ciliary (bovine) muscles were dissected and mounted in isometric force-transducer systems filled with aerated-solutions. Contraction was elicited using carbachol (10-6 M for iris sphincter, 10-5 M for ciliary muscle), prior adding to all testing substances. UCN2 induced relaxation in iris sphincter muscle, being the effect maximal at 10-7 M concentrations (-12.2 % variation vs. control). This effect was abolished with incubation of indomethacin, antisauvagine-30, chelerytrine and SQ22536, but preserved with L-nitro-L-arginine. In carbachol pre-stimulated ciliary muscle, UCN2 (10-5 M) enhanced contraction (maximal effect of 18.2 % increase vs. control). UCN2 is a new modulator of iris sphincter relaxation, dependent of CRF-R2 activation, synthesis of prostaglandins (COX pathway) and both adenylate cyclase and PKC signaling pathways, but independent of nitric oxide production. Regarding ciliary muscle, UCN2 enhances carbachol-induced contraction, in higher doses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here